| Dr Lancer Gentry Gates, DO | |
|
2750 Clay Edwards Dr Ste 200a, North Kansas City, MO 64116-3237 | |
| (816) 968-9320 | |
| Not Available |
| Full Name | Dr Lancer Gentry Gates |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 28 Years |
| Location | 2750 Clay Edwards Dr Ste 200a, North Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083611941 | NPI | - | NPPES |
| 245309117 | Medicaid | MO | |
| 28043027 | Other | MO | BLUE SHIELD KANSAS CITY |
| 200304460A | Medicaid | KS | |
| 5400729 | Other | MO | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 2000174342 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Liberty Hospital District | Liberty, MO | Hospital |
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gates Hospitalists Llc | 1759287527 | 12 |
News Archive
Gaumard Scientific Company today announced that its U.S. installations of the Victoria birthing simulator continue at a rapid pace as more health care educators select what is the industry's most advanced maternal-fetal simulator for their teaching purposes. Victoria installations now span 24 states in all regions and reflect the demand for advanced fully tetherless and wireless technology that Gaumard offers.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
The brains of teenage girls who engage in serious forms of self-harm, including cutting, show features similar to those seen in adults with borderline personality disorder, a severe and hard-to-treat mental illness, a new study has found.
McNeil Consumer & Specialty Pharmaceuticals has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the use of CONCERTA® (methylphenidate HCl) CII Extended-release Tablets in adolescents with Attention Deficit/Hyperactivity Disorder (ADHD) and to expand labeling to include a 72 mg dosing regimen.
Research on what makes the body clock tick has led Dr Michael Hastings of the MRC Laboratory of Molecular Biology in Cambridge to discover a new and unanticipated cog in the human body clock. A patent for the compound involved has been filed by MRC Technology. The results, published in Science, could lead to therapies for people whose sleep is disrupted by shift work or old age.
› Verified 3 days ago
| Entity Name | Gates Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699774893 PECOS PAC ID: 1759287527 Enrollment ID: O20031211000431 |
News Archive
Gaumard Scientific Company today announced that its U.S. installations of the Victoria birthing simulator continue at a rapid pace as more health care educators select what is the industry's most advanced maternal-fetal simulator for their teaching purposes. Victoria installations now span 24 states in all regions and reflect the demand for advanced fully tetherless and wireless technology that Gaumard offers.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
The brains of teenage girls who engage in serious forms of self-harm, including cutting, show features similar to those seen in adults with borderline personality disorder, a severe and hard-to-treat mental illness, a new study has found.
McNeil Consumer & Specialty Pharmaceuticals has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the use of CONCERTA® (methylphenidate HCl) CII Extended-release Tablets in adolescents with Attention Deficit/Hyperactivity Disorder (ADHD) and to expand labeling to include a 72 mg dosing regimen.
Research on what makes the body clock tick has led Dr Michael Hastings of the MRC Laboratory of Molecular Biology in Cambridge to discover a new and unanticipated cog in the human body clock. A patent for the compound involved has been filed by MRC Technology. The results, published in Science, could lead to therapies for people whose sleep is disrupted by shift work or old age.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lancer Gentry Gates, DO 2750 Clay Edwards Dr Ste 200a, N Kansas City, MO 64116-3237 Ph: (816) 968-9320 | Dr Lancer Gentry Gates, DO 2750 Clay Edwards Dr Ste 200a, North Kansas City, MO 64116-3237 Ph: (816) 968-9320 |
News Archive
Gaumard Scientific Company today announced that its U.S. installations of the Victoria birthing simulator continue at a rapid pace as more health care educators select what is the industry's most advanced maternal-fetal simulator for their teaching purposes. Victoria installations now span 24 states in all regions and reflect the demand for advanced fully tetherless and wireless technology that Gaumard offers.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
The brains of teenage girls who engage in serious forms of self-harm, including cutting, show features similar to those seen in adults with borderline personality disorder, a severe and hard-to-treat mental illness, a new study has found.
McNeil Consumer & Specialty Pharmaceuticals has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the use of CONCERTA® (methylphenidate HCl) CII Extended-release Tablets in adolescents with Attention Deficit/Hyperactivity Disorder (ADHD) and to expand labeling to include a 72 mg dosing regimen.
Research on what makes the body clock tick has led Dr Michael Hastings of the MRC Laboratory of Molecular Biology in Cambridge to discover a new and unanticipated cog in the human body clock. A patent for the compound involved has been filed by MRC Technology. The results, published in Science, could lead to therapies for people whose sleep is disrupted by shift work or old age.
› Verified 3 days ago
Dr. Iris Acosta Comes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr, Suite 240, North Kansas City, MO 64116 Phone: 816-455-0681 Fax: 816-455-5294 | |
Dr. Nicholas Andrew Szilagye, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Clay Edwards Dr, Suite 400, North Kansas City, MO 64116 Phone: 816-421-4240 Fax: 816-421-5015 | |
Dr. Rajya L Malay, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 520, North Kansas City, MO 64116 Phone: 816-221-6750 Fax: 816-221-7280 | |
Dr. Varaporn Treemaneekarn, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr, Suite 400, North Kansas City, MO 64116 Phone: 816-421-4240 Fax: 816-421-5015 | |
Stephenson Coe Hudson, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Clay Edwards Dr Ste 240, North Kansas City, MO 64116 Phone: 816-455-0681 Fax: 816-455-5294 | |
Dr. Mark Ernest Gordon, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 2700 Clay Edwards Dr, Suite 400, North Kansas City, MO 64116 Phone: 816-421-4240 Fax: 816-421-5015 |